https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-14 / Front Immunol 2015;6:663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-14 / Front Immunol 2015;6:6632016-01-14 00:00:002021-11-15 13:26:00Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-14 / World J. Gastroenterol. 2016 Jan;22(2):748-632016-01-14 00:00:002016-01-14 00:00:00Viro-immune therapy: A new strategy for treatment of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-11 / Int J Hyperthermia 2016;32(2):187-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-11 / Int J Hyperthermia 2016;32(2):187-922016-01-11 00:00:002019-02-15 08:39:26Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-61
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-612016-01-07 00:00:002019-02-15 08:47:51Current status and perspectives of immune-based therapies for hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-06 / Viruses 2016 Jan;8(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-06 / Viruses 2016 Jan;8(1)2016-01-06 00:00:002019-02-15 08:36:16Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-01 / 2016;62(1):47-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-01 / 2016;62(1):47-522016-01-01 00:00:002016-01-01 00:00:00Vitamin B6 Modifies the Immune Cross-Talk between Mononuclear and Colon Carcinoma Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-28 / Clin. Cancer Res. 2016 05;22(9):2155-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-28 / Clin. Cancer Res. 2016 05;22(9):2155-662015-12-28 00:00:002019-02-15 08:49:39Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-23 / Viruses 2015 Dec;8(1)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-23 / Viruses 2015 Dec;8(1)2015-12-23 00:00:002019-02-15 09:19:11Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-21 / J. Exp. Clin. Cancer Res. 2015 Dec;34:153
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-21 / J. Exp. Clin. Cancer Res. 2015 Dec;34:1532015-12-21 00:00:002019-02-15 09:22:50Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-87
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-21 / Int. J. Radiat. Oncol. Biol. Phys. 2016 Apr;94(5):1073-872015-12-21 00:00:002015-12-21 00:00:00Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysis
